593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis - Lee, S.S.; Powis, J.; Heathcote, E.J.; Sherman, M.; Bailey, R.J.; Feinman, S.V.; Baro, V.; Yoshidas, E.; Witt-Sullivan, H.B.; Peltekian, K. (Journal of Hepatology, 2006)